Professional Documents
Culture Documents
Abstract:
1. Introduction:
2. Case Report:
A 62 year old female patient, who is a retiree, complained of intermittent fever associated
with bilateral knee joint pain for a month. She was also diagnosed with hypertension 12
years back which she is on medication for. Examination did not reveal any organomegaly or
specific signs. Blood tests against scrub typhus, leptospirosis, brucellosis, dengue, and RT
PCR for SARS CoV-2 were all negative. In view of pyrexia of unknown origin, a PET scan
was done which showed mildly FDG avid diffuse periarticular sclerosis around bilateral
sacroiliac joints and bilateral knee joints, suggestive of inflammatory aetiology. ANA profile,
ANA (IF) and ANCA panel, were all negative. She was discharged, and prescribed
doxycycline, acetaminophen, and multivitamins. Due to persistent fever, a repeat Brucella
antibody panel was done two weeks after discharge, which showed a rising titre (1:80 -
Brucella melitensis and 1:160 - Brucella abortus) following which the patient was started on
streptomycin injections in addition to the oral doxycycline regimen. A follow up test showed a
reduced titre (1:80 - Brucella abortus and <1:40 - Brucella mellitensis.)
Two weeks following the test, the patient reported to the hospital complaining of difficulty in
walking, which was insidious in onset and progressive, as well as numbness in her limbs.
The patient was initially able to walk with a stick, and then unable to walk without a helper’s
support. Video nystagmography was performed to rule out vestibular causes of imbalance
due to aminoglycoside toxicity, and a nerve conduction velocity study was performed which
showed mild, distal, symmetrical, large fiber, sensory polyneuropathy involving bilateral
upper limbs. Electromyography showed chronic neurogenic changes in the distal muscles of
both upper and lower limbs with no active denervation. Liver and renal function tests were all
normal. A diagnosis of Brucellosis associated peripheral neuropathy was made and repeat
Brucella antibodies were negative. Patient was advised to continue the full course of the
antibiotics, and was discharged with some improvement in mobility.
Table 1: Results of Brucella antibody titres prior to, during, and post-treatment.
Pre-treatment (26/08/2020 +++ Brucella abortus 1:160 and Brucella melitensis 1:80
During treatment ++ Brucella abortus 1:80 and Brucella melitensis < 1:40
(25/09/2020/)
Post treatment (10/10/2020) - Brucella abortus <1:40 and Brucella melitensis < 1:40
Table 2: Prevalence of common presentations of Brucellosis as per various studies. [3]
3. Discussion:
Human brucellosis is not an uncommon infection in the Indian subcontinent, however the
peripheral neuropathy seen in cases, is usually sub clinical. [2] Apart from the sub clinical
aspect of peripheral neuropathy as a presentation in human Brucellosis, there is a paucity of
data available regarding its onset and prevalence.
References:
1. Anna S Dean, Lisa Crump, Helena Greter, Jan Hattendorf, Esther Schelling, Jakob
Zinsstag (2012) Clinical Manifestations of Human Brucellosis: A Systematic Review and
Meta-Analysis. PLoS Negl Trop Dis. 2012 Dec; 6(12): e1929 [PubMed]
2. Sanivar H, Kose Ozlece H, Huseyinoglu N, Aydin E, Ilik F (2017) Frequency of subclinical
peripheral neuropathy in cases of untreated brucellosis. J Infect Dev Ctries 11:753-758. doi:
10.3855/jidc.8056
3. Medscape Article.